Thiago Silva Torres
1
* , PhD ;
Kelika A Konda
2
* , PhD ;
E Hamid Vega-Ramirez
3, 4
* , MD, MSc ;
Oliver A Elorreaga
2
, MSc ;
Dulce Diaz-Sosa
3, 4
, PsyD ;
Brenda Hoagland
1
, MD, PhD ;
Steven Diaz
5
, MD ;
Cristina Pimenta
6
, PhD ;
Marcos Benedetti
1
, MSc ;
Hugo Lopez-Gatell
7
, PhD ;
Rebeca Robles-Garcia
4
, PhD ;
Beatriz Grinsztejn
1
, MD, PhD ;
Carlos Caceres
2
, MD, PhD ;
Valdilea G Veloso
1
, MD, PhD ;
ImPrEP Study Group
1, 2, 3
1
Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI/Fiocruz), Rio de Janeiro, Brazil
2
Centro de Investigación Interdisciplinaria en Sexualidad Sida y Sociedad, UPCH, Lima, Peru
3
Condesa & Condesa-Iztapalapa Specialized Clinics, Mexico City, Mexico
4
National Institute of Psychiatry Ramon de la Fuente Muñiz, Mexico City, Mexico
5
Center for Prevention and Comprehensive Healthcare for HIV/AIDS of Mexico City, Mexico City, Mexico
6
Brazilian Ministry of Health, Brasília, Brazil
7
National Institute of Public Health, Mexico City, Mexico
*these authors contributed equally
Corresponding Author:
-
Thiago Silva Torres, PhD
-
Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI/Fiocruz)
-
Av Brasil 4365 Manguinhos
-
Rio de Janeiro, 21040-900
-
Brazil
-
Phone:
55 38659623
-
Fax: 55 38659679
-
Email: thiago.torres@ini.fiocruz.br